-+ 0.00%
-+ 0.00%
-+ 0.00%

TELOMIR PHARMACEUTICALS SELECTS LINICAL TO ADVANCE FDA-CLEARED PHASE 1/2 CLINICAL TRIAL OF TELOMIR-ZN IN TRIPLE-NEGATIVE BREAST CANCER

路透·11/18/2026 13:00:00

请登录查看新闻详情